Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Pfizer |
---|---|
Information provided by: | Pfizer |
ClinicalTrials.gov Identifier: | NCT00444548 |
[S,S]-Reboxetine will be used to evaluate pharmacodynamic changes in urethral function in healthy volunteers using a novel methodology
Condition | Intervention |
---|---|
Healthy |
Drug: [S,S]-Reboxetine |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Pharmacodynamics Study |
Official Title: | Measurement Of Urethral Function In Healthy Female Volunteers - Evaluation Of The Sensitivity of Urethral Reflectometry Compared To Urethral Pressure Profilometry, Using [S,S]-Reboxetine. |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | A6061028 |
Study First Received: | March 6, 2007 |
Last Updated: | August 20, 2007 |
ClinicalTrials.gov Identifier: | NCT00444548 History of Changes |
Health Authority: | Danish Dataprotection Agency, Danish Medicines Agency and Ethics Committee Denmark: |
Equipment Supplies |
Neurotransmitter Agents Adrenergic Agents Psychotropic Drugs |
Healthy Antidepressive Agents Reboxetine |
Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Adrenergic Uptake Inhibitors Therapeutic Uses |
Physiological Effects of Drugs Psychotropic Drugs Central Nervous System Agents Pharmacologic Actions Antidepressive Agents Reboxetine |